The DOI matches its Crossref record; 69 of the 69 references it cites were found in a registry or an index.
Ocular drug delivery
Abstract
Drug delivery to the eye is hampered by anatomical factors, including the corneal epithelium, the blood-aqueous barrier and the blood-retinal barrier. This review aims to outline the major routes of ocular drug delivery, including systemic, topical, periocular and intravitreal. The pharmacokinetics, the disadvantages and the clinical relevance of these drug delivery routes have been emphasised. Recent advances in surgical techniques, therapeutic approaches and material sciences have produced exciting new therapies for ocular diseases. The role of ophthalmic drug formulation in targeting the desired ocular tissue and enhancing drug delivery by the chosen route whilst minimising side effects is also discussed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
De Campos, A. M., Sánchez, A., & Alonso, M. J. (2001) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(01)00760-8 · Cited by 666
Permeability of cornea, sclera, and conjunctiva: A literature analysis for drug delivery to the eye
Prausnitz, M. R., & Noonan, J. S. (1998) · Journal of Pharmaceutical Sciences · doi:10.1021/js9802594 · Cited by 627
OLTHOFF, C., SCHOUTEN, J., VANDEBORNE, B., & WEBERS, C. (2005) · Ophthalmology · doi:10.1016/j.ophtha.2004.12.035 · Cited by 494
de Campos, A. M., Diebold, Y., Carvalho, E. L. S., Sánchez, A., & José Alonso, M. (2004) · Pharmaceutical Research · doi:10.1023/b:pham.0000026432.75781.cb · Cited by 404
Acute endophthalmitis following intravitreal triamcinolone acetonide injection
Moshfeghi, D. M., Kaiser, P. K., Scott, I. U., Sears, J. E., Benz, M., Sinesterra, J. P., Kaiser, R. S., Bakri, S. J., Maturi, R. K., Belmont, J., et al. (2003) · American Journal of Ophthalmology · doi:10.1016/s0002-9394(03)00483-5 · Cited by 397
FATAL BENZYL ALCOHOL POISONING IN A NEONATAL INTENSIVE CARE UNIT
Brown, W., Buist, N. M., Cory Gipson, H., Huston, R., & Kennaway, N. (1982) · The Lancet · doi:10.1016/s0140-6736(82)92377-7 · Cited by 397
Importance of the noncorneal absorption route in topical ophthalmic drug delivery.
Ahmed, I., & Patton, T. F. (1985) · PubMed · Cited by 357
Human sclera: Thickness and surface area
Olsen, T. W., Aaberg, S. Y., Geroski, D. H., & Edelhauser, H. F. (1998) · American Journal of Ophthalmology · doi:10.1016/s0002-9394(99)80096-8 · Cited by 349
Self-citationPenetration Enhancers and Ocular Bioadhesives: Two New Avenues for Ophthalmic Drug Delivery
Kaur, I. P., & Smitha, R. (2002) · Drug Development and Industrial Pharmacy · doi:10.1081/ddc-120002997 · Cited by 305
Rozier, A., Mazuel, C., Grove, J., & Plazonnet, B. (1989) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(89)90305-0 · Cited by 266
Periocular routes for retinal drug delivery
Raghava, S., Hammond, M., & Kompella, U. B. (2004) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.1.1.99 · Cited by 257
Kompella, U. B., Bandi, N., & Ayalasomayajula, S. P. (2003) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.02-0791 · Cited by 239
Olsen, T. W., Edelhauser, H. F., Lim, J. I., & Geroski, D. H. (1995) · PubMed · Cited by 230
Self-citationEffect of poloxamer 407 gel on the miotic activity of pilocarpine nitrate in rabbits
Miller, S. C., & Donovan, M. D. (1982) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(82)90114-4 · Cited by 210
Improved Ocular Bioavailability of Indomethacin by Novel Ocular Drug Carriers
Calvo, P., Alonso, M. J., Vila-Jato, J. L., & Robinson, J. R. (1996) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.1996.tb03911.x · Cited by 206
Physicochemical Determinants of Drug Diffusion Across the Conjunctiva, Sclera, and Cornea
Ahmed, I., Gokhale, R. D., Shah, M. V., & Patton, T. F. (1987) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600760802 · Cited by 195
Applications of Liposomes in Ophthalmology
Ebrahim, S., Peyman, G. A., & Lee, P. J. (2005) · Survey of Ophthalmology · doi:10.1016/j.survophthal.2004.12.006 · Cited by 193
Comparison of conjunctival and corneal surface areas in rabbit and human
Watsky, M. A., Jablonski, M. M., & Edelhauser, H. F. (1988) · Current Eye Research · doi:10.3109/02713688809031801 · Cited by 192
Self-citationHigh concentration of dexamethasone in aqueous and vitreous after subconjunctival injection
Weijtens, O., Feron, E. J., Schoemaker, R. C., Cohen, A. F., Lentjes, E. G. W. M., Romijn, F. P. H. T. M., & van Meurs, J. C. (1999) · American Journal of Ophthalmology · doi:10.1016/s0002-9394(99)00129-4 · Cited by 188
Complications of intravitreal injection of triamcinolone acetonide
Özkiriş, A., & Erkiliç, K. (2005) · Canadian Journal of Ophthalmology · doi:10.1016/s0008-4182(05)80119-x · Cited by 172
Van Santvliet, L., & Ludwig, A. (2004) · Survey of Ophthalmology · doi:10.1016/j.survophthal.2003.12.009 · Cited by 167
Pseudo-endophthalmitis after intravitreal injection of triamcinolone
Sutter, F. K. P. (2003) · British Journal of Ophthalmology · doi:10.1136/bjo.87.8.972 · Cited by 166
Controlled Delivery of the Anti-VEGF Aptamer EYE001 with Poly(lactic-co-glycolic)Acid Microspheres
Carrasquillo, K. G., Ricker, J. A., Rigas, I. K., Miller, J. W., Gragoudas, E. S., & Adamis, A. P. (2003) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.01-1156 · Cited by 163
Bioadhesive Microspheres for Ophthalmic Administration of Acyclovir
Genta, I., Conti, B., Perugini, P., Pavanetto, F., Spadaro, A., & Puglisi, G. (1997) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.1997.tb06103.x · Cited by 162
Penetration Routes of Topically Applied Eye Medications
Doane, M. G., Jensen, A. D., & Dohlman, C. H. (1978) · American Journal of Ophthalmology · doi:10.1016/s0002-9394(14)77735-9 · Cited by 158
Jaffe, G. J., McCallum, R. M., Branchaud, B., Skalak, C., Butuner, Z., & Ashton, P. (2005) · Ophthalmology · doi:10.1016/j.ophtha.2005.03.013 · Cited by 158
Review: Practical Issues in Intravitreal Drug Delivery
Maurice, D. M. (2001) · Journal of Ocular Pharmacology and Therapeutics · doi:10.1089/108076801753162807 · Cited by 153
Permeability and Diffusion in Vitreous Humor: Implications for Drug Delivery
Xu, J., Heys, J. J., Barocas, V. H., & Randolph, T. W. (2000) · Pharmaceutical Research · doi:10.1023/a:1007517912927 · Cited by 147
Drug Delivery and Targeting : For Pharmacists and Pharmaceutical Scientists
Hillery, A. M., Lloyd, A. W., & Swarbrick, J. (2001) · Cited by 144
Comparative Toxicity of Intravitreal Aminoglycoside Antibiotics
D’Amico, D. J., CASPERS-VELU, L. E., Libert, J., Shanks, E., Schrooyen, M., Hanninen, L. A., & Kenyon, K. R. (1985) · American Journal of Ophthalmology · doi:10.1016/0002-9394(85)90792-5 · Cited by 139
Clinical pharmacokinetics of the eye. Proctor lecture.
Mishima, S. (1981) · PubMed · Cited by 133
Albumin Nanoparticles for the Intravitreal Delivery of Anticytomegaloviral Drugs
Irache, J. M., Merodio, M., Arnedo, A., Camapanero, M., Mirshahi, M., & Espuelas, S. (2005) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/1389557053175335 · Cited by 131
Gene transfer with liposomes to the intraocular tissues by different routes of administration.
Masuda, I., Matsuo, T., Yasuda, T., & Matsuo, N. (1996) · PubMed · Cited by 115
Weijtens, O., van der Sluijs, F. A., Schoemaker, R. C., Lentjes, E. G. W. M., Cohen, A. F., Romijn, F. P. H. T. M., & MEURS, J. C. V. (1997) · American Journal of Ophthalmology · doi:10.1016/s0002-9394(14)70131-x · Cited by 115
Biodegradable scleral plugs for vitreoretinal drug delivery
Yasukawa, T., Kimura, H., Tabata, Y., & Ogura, Y. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(01)00192-2 · Cited by 114
Effect of Particle Size on Ophthalmic Bioavailability of Dexamethasone Suspensions in Rabbits
Schoenwald, R. D., & Stewart, P. (1980) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600690407 · Cited by 112
Schmidt-Erfurth, U. M., Hasan, T. G., Schomacker, K. T., Flotte, T. J., & Birngruber, R. (1995) · Lasers in Surgery and Medicine · doi:10.1002/lsm.1900170207 · Cited by 99
Saishin, Y., Silva, R. L., Saishin, Y., Callahan, K. P., Schoch, C., Ahlheim, M., Lai, H. C., Kane, F. E., Brazzell, R. K., Bodmer, D., et al. (2003) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.03-0600 · Cited by 94
Intravitreal sustained-release cyclosporine in the treatment of experimental uveitis
Jaffe, G. J., Yang, C., Wang, X., et al. (1998) · Ophthalmology · doi:10.1016/s0161-6420(98)91176-9 · Cited by 93
Increased human scleral permeability with prostaglandin exposure.
Kim, J. W., Lindsey, J. D., Wang, N., & Weinreb, R. N. (2001) · PubMed · Cited by 91
Kinetics of macromolecules injected into the subretinal space
Marmor, M. F., Negi, A., & Maurice, D. M. (1985) · Experimental Eye Research · doi:10.1016/0014-4835(85)90138-1 · Cited by 91
Subconjunctival Carboplatin in Fibrin Sealant in the Treatment of Transgenic Murine Retinoblastoma
VANQUILL, K., Dioguardi, P. K., TONG, C., Gilbert, J. A., AABERGJR, T., Grossniklaus, H. E., EDELHAUSER, H., & OBRIEN, J. (2005) · Ophthalmology · doi:10.1016/j.ophtha.2004.11.060 · Cited by 91
Self-citationWeijtens, O., Schoemaker, R. C., Lentjes, E. G. W. M., Romijn, F. P. H. T. M., Cohen, A. F., & van Meurs, J. C. (2000) · Ophthalmology · doi:10.1016/s0161-6420(00)00344-4 · Cited by 90
Movement of Albumin and Dextran Through the Sclera
Bill, A. (1965) · Archives of Ophthalmology · doi:10.1001/archopht.1965.00970040250024 · Cited by 82
Drug delivery through the sclera: effects of thickness, hydration, and sustained release systems
Lee, S.-B., Geroski, D. H., Prausnitz, M. R., & Edelhauser, H. F. (2003) · Experimental Eye Research · doi:10.1016/s0014-4835(03)00211-2 · Cited by 79
Self-citationColo, G. D., Zambito, Y., Burgalassi, S., et al. (2002) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(02)00421-0 · Cited by 77
Iontophoresis: from the lab to the bed side
Halhal, M., Renard, G. J., Courtois, Y., et al. (2003) · Experimental Eye Research · doi:10.1016/j.exer.2003.10.017 · Cited by 76
Naveh, N., Muchtar, S., & Benita, S. (1994) · Journal of Ocular Pharmacology and Therapeutics · doi:10.1089/jop.1994.10.509 · Cited by 71
Prostaglandin FP Agonists Alter Metalloproteinase Gene Expression in Sclera
Weinreb, R. N., Lindsey, J. D., Marchenko, G., Marchenko, N. D., Angert, M., & Strongin, A. Y. (2004) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.04-0413 · Cited by 71
Takahashi, T., Nakamura, T., Hayashi, A., Kamei, M., Nakabayashi, M., Okada, A. A., Tomita, N., Kaneda, Y., & Tano, Y. (2000) · American Journal of Ophthalmology · doi:10.1016/s0002-9394(00)00772-8 · Cited by 69
Berger, A., Cheng, C.-K., Pearson, P. A., Ashton, P., Crooks, P. A., Cynkowski, T., Cynkowska, G., & Jaffe, G. J. (1996) · PubMed · Cited by 67
Lee, T. W.-Y., & Robinson, J. R. (2001) · Journal of Ocular Pharmacology and Therapeutics · doi:10.1089/10807680152729257 · Cited by 66
Cefazolin levels after intravitreal injection. Effects of inflammation and surgery.
Ficker, L. A., Meredith, T. A., Gardner, S. K., & Wilson, L. A. (1990) · PubMed · Cited by 64
Effect of Benzalkonium Chloride on Transscleral Drug Delivery
Okabe, K., Kimura, H., Okabe, J., Kato, A., Shimizu, H., Ueda, T., Shimada, S., & Ogura, Y. (2005) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.03-0934 · Cited by 64
Posterior drainage of the intraocular fluid from the vitreous
Hayreh, S. S. (1966) · Experimental Eye Research · doi:10.1016/s0014-4835(66)80029-5 · Cited by 63
Okabe, K., Kimura, H., Okabe, J., Kato, A., Kunou, N., & Ogura, Y. (2003) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.02-0956 · Cited by 62
Novel approaches for retinal drug delivery
Kurz, D. E., & Ciulla, T. A. (2002) · Ophthalmology Clinics of North America · doi:10.1016/s0896-1549(02)00034-2 · Cited by 61
The effect of intraocular pressure on human and rabbit scleral permeability.
Rudnick, D. E., Noonan, J. S., Geroski, D. H., Prausnitz, M. R., & Edelhauser, H. F. (1999) · PubMed · Cited by 57
Self-citationEnhancement of scleral macromolecular permeability with prostaglandins.
Weinreb, R. N. (2001) · PubMed · Cited by 46
Transscleral permeability and intraocular concentrations of cisplatin from a collagen matrix
Gilbert, J. A., Simpson, A. E., Rudnick, D. E., Geroski, D. H., Aaberg, T. M., & Edelhauser, H. F. (2003) · Journal of Controlled Release · doi:10.1016/s0168-3659(03)00151-2 · Cited by 44
Self-citationA histopathologic study of retinal lesions inflicted by transscleral iontophoresis
Lam, T. T., Fu, J., & Tso, M. O. M. (1991) · Graefe s Archive for Clinical and Experimental Ophthalmology · doi:10.1007/bf00170699 · Cited by 39
Influence of Hydroxypropyl β-Cyclodextrin on the Corneal Permeation of Pilocarpine
Aktaş, Y., Ünlü, N., Orhan, M., Irkec, M. T., & Hıncal, A. A. (2003) · Drug Development and Industrial Pharmacy · doi:10.1081/ddc-120016730 · Cited by 38
Leibowitz, H. M., & Kupferman, A. (1976) · Archives of Ophthalmology · doi:10.1001/archopht.1976.03910040255019 · Cited by 31
Transscleral Permeability of Fluorescent-Labeled Antibiotics
Kao, J. C., Geroski, D. H., & Edelhauser, H. F. (2005) · Journal of Ocular Pharmacology and Therapeutics · doi:10.1089/jop.2005.21.1 · Cited by 29
Self-citationExternally Triggered Release of Dye and Drugs from Lyposomes into the eye
Khoobehi, B., Peyman, G. A., McTurnan, W. G., Niesman, M. R., & Magin, R. L. (1988) · Ophthalmology · doi:10.1016/s0161-6420(88)33070-8 · Cited by 28
Scleral Permeability of a Small, Single-Stranded Oligonucleotide
Shuler, R. K., Dioguardi, P. K., Henjy, C., Nickerson, J. M., Cruysberg, L. P. J., & Edelhauser, H. F. (2004) · Journal of Ocular Pharmacology and Therapeutics · doi:10.1089/108076804773710830 · Cited by 27
Self-citationDrainage of Microspheres and RBCs From the Vitreous of Aphakic and Phakic Eyes
Algvere, P. V., & Bill, A. (1979) · Archives of Ophthalmology · doi:10.1001/archopht.1979.01020020075018 · Cited by 24
Gellan-Based Scleral Implants of Indomethacin: In Vitro and In Vivo Evaluation
Balasubramaniam, J., Kumar, M., Pandit, J. K., & Kant, S. (2004) · Drug Delivery · doi:10.1080/10717540490884787 · Cited by 22
Maestrelli, F., Mura, P., Casini, A., Mincione, F., Scozzafava, A., & Supuran, C. T. (2002) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.10215 · Cited by 22
Cited by
Gaudana, R., Ananthula, H. K., Parenky, A., & Mitra, A. K. (2010) · The AAPS Journal · doi:10.1208/s12248-010-9183-3 · Cited by 1,406
A comprehensive insight on ocular pharmacokinetics
Agrahari, V., Mandal, A., Agrahari, V., Trinh, H. M., Joseph, M., Ray, A., Hadji, H., Mitra, R., Pal, D., & Mitra, A. K. (2016) · Drug Delivery and Translational Research · doi:10.1007/s13346-016-0339-2 · Cited by 462
Advances and limitations of drug delivery systems formulated as eye drops
Jumelle, C., Gholizadeh, S., Annabi, N., & Dana, R. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.01.057 · Cited by 408
Nanotechnology-based strategies for treatment of ocular disease
Weng, Y., Liu, J., Jin, S., Guo, W., Liang, X., & Hu, Z. (2017) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2016.09.001 · Cited by 375
Chitosan-based nanostructures: A delivery platform for ocular therapeutics
de la Fuente, M., Raviña, M., Paolicelli, P., Sanchez, A., Seijo, B., & Alonso, M. J. (2010) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2009.11.026 · Cited by 354
Metadata
- Authors
- Ghate, D., & Edelhauser, H. F.
- Venue
- Expert Opinion on Drug Delivery
- Publisher
- Informa Healthcare
- Published
- 2006-02-28
- Volume
- 3
- Issue
- 2
- Pages
- 275-287
- ISSN
- 1742-5247 (ISSN-L)
- 1744-7593
- OpenAlex
- W2072399777
- Cited by
- 329
- References
- 69
- FWCI
- 8.56
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.